Skip to content

Utilizing Tailored Step-Count Feedback to Enhance Physical Activity in the Elderly

Utilizing Tailored Step-Count Feedback to Enhance Physical Activity in the Elderly

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01158638
Acronym
StepCount
Enrollment
160
Registered
2010-07-08
Start date
2009-08-31
Completion date
2016-07-31
Last updated
2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly, Physical Activity

Keywords

Physical Activity Enhancement

Brief summary

Individually tailored, mediated pedometer feedback will provide an effective method to promote physical activity adoption in the elderly

Interventions

BEHAVIORALWeb Mediated Step Intervention

The testing of a web mediated step intervention designed to set weekly step targets, and channel participants through a series of motivational screens depending on compliance or non-compliance with set step goals.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Wisconsin, Milwaukee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male or female individuals living in the community. 2. Aged between 50 and 85 years, at screening. 3. Sufficient physical function not to have limitations to participate in physical activity demonstrated by: * Habitual gait speed ≥ 1.5 mph, AND * No use of a cane or walker, AND * Able to walk ≥ 50 feet unaided 4. Sufficient cognitive function, as demonstrated by responses to the mini-mental state examination(\>23 score). 5. Be able to read and write in English 6. Sedentary behavior, demonstrated by no regular activity / exercise for previous 6 months and/or a Stage of Change 2 and 3

Exclusion criteria

1. Presence of a rapidly progressive or terminal illness condition that is expected to result in significant functional decline during the course of the proposed studies. 2. Significant uncontrolled cardiovascular disease and conditions, e.g. unstable or new onset angina, unrepaired aortic aneurysms, critical aortic stenosis or CAD without bypass, persistent moderate to severe uncontrolled hypertension. 3. Significant uncontrolled metabolic disease, e.g. hemoglobin A1c levels greater than 8.0 and/or glucose levels greater than 300 mg/dL. 4. Fracture of lower extremity within three months. 5. Amputation other than toes. 6. Current history of severe arthritis or orthopedic condition precluding physical activity. 7. Participation in any regular structured exercise (resistance training, Tai Chi, high intensity walking, jogging, cycling, stair climbing, stepping, within the previous 6 months. 8. Individuals that start a new medication that can impact health variables examined during study period (e.g., beta blockers, glucose or cholesterol altering medications), or individuals who alter medication dose that can impact health variables examined within study period.

Design outcomes

Primary

MeasureTime frameDescription
Objectively assessed steps per day12 weeksPedometer determined physical activity

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026